Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhe Sheng

Showing results (441-450 of 633) with videos related to

Pageof 64
Sort By:
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 26, 2024
NAT10 Promotes Prostate Cancer Growth and Metastasis by Acetylating mRNAs of HMGA1 and KRT8Kang-Jing Li, Yaying Hong, Yu-Zhong Yu, et al.
Molecules (Basel, Switzerland)|December 6, 2019
Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 ExpressionDan Liao, Wei Zhang, Pranav Gupta, et al.
Acta Pharmaceutica Sinica. B|September 20, 2017
Establishment and characterization of arsenic trioxide resistant KB/ATO cellsYun-Kai Zhang, Chunling Dai, Chun-Gang Yuan, et al.
Chinese Medicine|December 31, 2022
Isolation, bioassay and 3D-QSAR analysis of 8-isopentenyl flavonoids from Epimedium sagittatum maxim. as PDE5A inhibitorsJuntao Li, Yue Wu, Xinxin Yu, et al.
Breast Cancer Research and Treatment|August 28, 2012
Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 productionZhi Shi, Wei-Min Yang, Li-Pai Chen, et al.
Biochemical Pharmacology|June 18, 2014
Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1Yi-Jun Wang, Rishil J Kathawala, Yun-Kai Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 17, 2023
MYH10 Combines with MYH9 to Recruit USP45 by Deubiquitinating Snail and Promotes Serous Ovarian Cancer Carcinogenesis, Progression, and Cisplatin ResistanceLongyang Liu, Chunlin Chen, Ping Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 28, 2026
Homoisoflavanone Delays Colorectal Cancer Progression via DNA Damage-Induced Mitochondrial Apoptosis and Parthanatos-Like Cell DeathHongjie Fan, Huzi Zhao, Pei Zhang, et al.
Clinical Nuclear Medicine|December 9, 2025
[18F]AlF-NOTA-PCP2 PET/CT to Assess PD-L1 Status in Head and Neck Cancer: Head-to-Head Comparison With [18F]FDG PET/CTYong Wang, Zhiguo Liu, Yang Li, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 29, 2024
Stepwise targeted strategies for improving neurological function by inhibiting oxidative stress levels and inflammation following ischemic strokeYi Li, Jun Liao, Liyan Xiong, et al.
Pageof 64

Showing results (441-450 of 633) with videos related to

Sort By:
Pageof 64
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|June 26, 2024
NAT10 Promotes Prostate Cancer Growth and Metastasis by Acetylating mRNAs of HMGA1 and KRT8Kang-Jing Li, Yaying Hong, Yu-Zhong Yu, et al.
Molecules (Basel, Switzerland)|December 6, 2019
Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 ExpressionDan Liao, Wei Zhang, Pranav Gupta, et al.
Acta Pharmaceutica Sinica. B|September 20, 2017
Establishment and characterization of arsenic trioxide resistant KB/ATO cellsYun-Kai Zhang, Chunling Dai, Chun-Gang Yuan, et al.
Chinese Medicine|December 31, 2022
Isolation, bioassay and 3D-QSAR analysis of 8-isopentenyl flavonoids from Epimedium sagittatum maxim. as PDE5A inhibitorsJuntao Li, Yue Wu, Xinxin Yu, et al.
Breast Cancer Research and Treatment|August 28, 2012
Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 productionZhi Shi, Wei-Min Yang, Li-Pai Chen, et al.
Biochemical Pharmacology|June 18, 2014
Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1Yi-Jun Wang, Rishil J Kathawala, Yun-Kai Zhang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 17, 2023
MYH10 Combines with MYH9 to Recruit USP45 by Deubiquitinating Snail and Promotes Serous Ovarian Cancer Carcinogenesis, Progression, and Cisplatin ResistanceLongyang Liu, Chunlin Chen, Ping Liu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 28, 2026
Homoisoflavanone Delays Colorectal Cancer Progression via DNA Damage-Induced Mitochondrial Apoptosis and Parthanatos-Like Cell DeathHongjie Fan, Huzi Zhao, Pei Zhang, et al.
Clinical Nuclear Medicine|December 9, 2025
[18F]AlF-NOTA-PCP2 PET/CT to Assess PD-L1 Status in Head and Neck Cancer: Head-to-Head Comparison With [18F]FDG PET/CTYong Wang, Zhiguo Liu, Yang Li, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 29, 2024
Stepwise targeted strategies for improving neurological function by inhibiting oxidative stress levels and inflammation following ischemic strokeYi Li, Jun Liao, Liyan Xiong, et al.
Pageof 64